Concepedia

Author

Anne-Kathrin Garz

Ludwig-Maximilians-Universität München

Also Known As

A.K. Garz, Anne-Kathrin Garz

15

Publications

1.3K

Citations

7

H-Index

13

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenGerman Cancer Research CenterTechnical University of MunichKlinikum rechts der IsarHeidelberg University
AG

About

Anne-Kathrin Garz is an author at Ludwig-Maximilians-Universität München specializing in medicine, cancer research, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

1K

2

Cell Biology

2

2

1K

3

Immunology

1

1

180

4

Pharmacology

1

1

845

5

Drug Discovery

1

1

845

Anne-Kathrin Garz

×

5

Publications

1.1K

Citations

5

H-Index

YearCitations

The target landscape of clinical kinase drugs

Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm,

Science

2017

845

Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity

Ruth Eichner, Michael Heider, Vanesa Fernández‐Sáiz,

Nature Medicine

2016

180

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma

Michael Heider, Ruth Eichner, Jacob Stroh,

Molecular Cell

2021

61

Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis

Catharina Wenk, Anne-Kathrin Garz, Sonja Grath,

Blood Advances

2018

41

Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in <i>FLT3</i>-ITD AML with concurrent epigenetic mutations

Anne-Kathrin Garz, Saskia Wolf, Sonja Grath,

Oncotarget

2017

14

Page 1